Bicara Therapeutics Inc. Common Stock
USD28.15
+1.00 (+3.68%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.18
Prev. Close
$27.15
Day Low
$27.05
Day High
$28.32
52W Low
$9.57
52W High
$30.99
Market Cap
$1.54B
Volume
0.28M
| -13.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -23.8% | -22.2% | 0.00 | 15.32 | -23.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 219.0% | -564.6% | 0.00 | 0.21 | -32.0 |
| -6.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -9.0% | -8.6% | 0.00 | 14.14 | -5.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -6.3% | -6.0% | 0.01 | 25.80 | -4.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.0% | -7.7% | 0.00 | 24.62 | -4.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -4.3% | -3.7% | 0.00 | 27.93 | -11.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -3.4% | -3.3% | 0.00 | 36.01 | -19.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 9.8% | -8.2% | -0.00 | 12.83 | -18.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.5% | -6.0% | 0.00 | 12.83 | -25.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -5.7% | -5.3% | 0.00 | 15.32 | -25.0 |